UMIN ID: UMIN000045563
Registered date:24/09/2021
Web-survey for atopic dermatitis control in Japan
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | Atopic dermatitis |
Date of first enrollment | 2021/09/24 |
Target sample size | 6200 |
Countries of recruitment | Japan |
Study type | Observational |
Intervention(s) |
Outcome(s)
Primary Outcome | Correlation coefficient between the ADCT score and each of the four following scores (DLQI/POEM/Worst Itch-NRS (WI-NRS)/GQ) |
---|---|
Secondary Outcome | -ADCT scores overall and by demographic characteristics (demographic characteristics: Age, gender, occupation, annual income, household composition, area of residence, and lifestyle) -Demographic characteristics by dupilumab users and non-users -Dosing patterns of dupilumab users (how long administered, whether or not they have ever discontinued it, length of temporary discontinuations) -ADCT and four (DLQI/POEM/WI-NRS/GQ) scores among dupilumab users and non-users |
Key inclusion & exclusion criteria
Age minimum | 20years-old |
---|---|
Age maximum | Not applicable |
Gender | Male and Female |
Include criteria | |
Exclude criteria | -Applicable to inappropriate responses |
Related Information
Primary Sponsor | Sanofi K.K. |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Sanofi K.K. |
Secondary ID(s) |
Contact
public contact | |
Name | Tomoyuki Kusaka |
Address | NMF Shinjuku East Bldg. 10-5 Tomihisacho, Shinjuku-ku, Tokyo 162-0067 JAPAN Japan 162-0067 |
Telephone | 03-6709-9710 |
HOR@ssri.com | |
Affiliation | Social Survey Research Information Co., Ltd. Healthcare BI & MA Service Division Health Outcomes Research |
scientific contact | |
Name | Tomoyuki Kusaka |
Address | NMF Shinjuku East Bldg. 10-5 Tomihisacho, Shinjuku-ku, Tokyo 162-0067 JAPAN Japan |
Telephone | 03-6709-9710 |
tkusaka@ssri.com | |
Affiliation | Social Survey Research Information Co., Ltd. Healthcare BI & MA Service Division Health Outcomes Research |